Your browser doesn't support javascript.
loading
Glycoprotein 130 receptor signaling mediates α-cell dysfunction in a rodent model of type 2 diabetes.
Chow, Samuel Z; Speck, Madeleine; Yoganathan, Piriya; Nackiewicz, Dominika; Hansen, Ann Maria; Ladefoged, Mette; Rabe, Björn; Rose-John, Stefan; Voshol, Peter J; Lynn, Francis C; Herrera, Pedro L; Müller, Werner; Ellingsgaard, Helga; Ehses, Jan A.
Afiliação
  • Chow SZ; Department of Surgery, Faculty of Medicine, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada.
  • Speck M; Department of Surgery, Faculty of Medicine, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada.
  • Yoganathan P; Department of Surgery, Faculty of Medicine, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada.
  • Nackiewicz D; Department of Surgery, Faculty of Medicine, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada.
  • Hansen AM; Diabetes Research Unit, Novo Nordisk A/S, Måløv, Denmark.
  • Ladefoged M; Diabetes Research Unit, Novo Nordisk A/S, Måløv, Denmark.
  • Rabe B; Institute of Biochemistry, Medical Faculty, Christian Albrechts University of Kiel, Kiel, Germany.
  • Rose-John S; Institute of Biochemistry, Medical Faculty, Christian Albrechts University of Kiel, Kiel, Germany.
  • Voshol PJ; Institute of Metabolic Science, University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, U.K.
  • Lynn FC; Department of Surgery, Faculty of Medicine, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada.
  • Herrera PL; Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Müller W; Faculty of Life Sciences, University of Manchester, Manchester, U.K.
  • Ellingsgaard H; The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Ehses JA; Department of Surgery, Faculty of Medicine, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada ehses@mail.ubc.ca.
Diabetes ; 63(9): 2984-95, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24812426
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Células Secretoras de Glucagon / Receptor gp130 de Citocina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Células Secretoras de Glucagon / Receptor gp130 de Citocina Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article